Device Trial Radar · NCT04010123
Post-Market Clinical Follow Up of Rotarex®S Catheter
Last checked: Nov 20, 2026Latest source record: Feb 9, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
220
Actual
Start
Jul 17, 2019
Primary completion
Oct 26, 2022
Study completion Oct 26, 2022
Sponsor
- Lead sponsor
- Straub Medical AGNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 8, 2019
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Post-Market Clinical Follow Up of the Rotarex®S Catheter
Conditions
- Peripheral Arterial Disease
Interventions
Atherectomy/ThrombectomyDevice
Percutaneous transluminal removal of thrombotic, thromboembolic and atherothrombotic material from fresh, subacute and chronic occlusions of blood vessels in native blood vessels or vessels fitted with stents, stent grafts or native or artificial bypasses.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from major adverse events (MAE)Time frame: 30 days
Locations
13 sites in 5 countries. Site status is shown where the registry gives one.
Angiocentrum Příbram
Příbram, Czechia
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.